Filter posts

Four Questions for the Energy and Commerce Hearing on 340B

Later this morning, the House Energy and Commerce Committee will hold a hearing to examine …

FDA Protects Patients While Promoting Innovation

Today, 83 percent of children with cancer survive, compared to just 58 percent in the …

I-MAK’s Distorted View of the U.S. Patent System

In an opinion piece published at CNBC.com, Tahir Amin — co-founder of I-MAK — blames …

Co-Pay Accumulator Programs Are a Bad Deal for Patients

As we see time and time again, health insurance providers and pharmacy benefit managers (PBMs) …

House Passes SUPPORT for Patients and Communities Act to Combat America’s Opioid Crisis

Opioid abuse and addiction in America has reached epidemic heights. As a nation, we’re spending …

New Report Offers “Distorted View” of Biopharma Industry

This week, the Minority Staff of the U.S. Senate Committee on Finance released a report …

Insurers Shift Costs and Facts

As health insurance companies begin setting rates for 2019, many consumers are once again faced …

Future Leaders in Biotechnology

BIO’s International Convention was packed with compelling keynote speeches, and dozens of fireside chats and …

Heralding In A New Era of Precision Medicine

The healthcare ecosystem is experiencing an acceleration in the uptake of the precision medicine paradigm …

Defining and Communicating Value

BIO President and CEO Jim Greenwood has defined value-based agreements as an important part of …